Eva Maria Hodel

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

Kenneth Kintu, Thokozile R. Malaba, Jesca Nakibuka et al. · The Lancet HIV · 2020 · 125 citations · Full text

Medicine, Infectious Diseases, Obstetrics +16

A single LC–tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma

Eva Maria Hodel, Boris Zanolari, Thomas Mercier et al. · Journal of Chromatography B · 2009 · 118 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +16

Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

Catriona Waitt, Catherine Orrell, Stephen Walimbwa et al. · PLoS Medicine · 2019 · 110 citations · Full text

Medicine, Maternal Health, Pharmacokinetics +17

How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?

Ian M. Hastings, Katherine Kay, Eva Maria Hodel · Antimicrobial Agents and Chemotherapy · 2015 · 70 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +13

Effect of Single Nucleotide Polymorphisms in Cytochrome P450 Isoenzyme and<i>N</i>-Acetyltransferase 2 Genes on the Metabolism of Artemisinin-Based Combination Therapies in Malaria Patients from Cambodia and Tanzania

Eva Maria Hodel, Chantal Csajka, Frédéric Ariey et al. · Antimicrobial Agents and Chemotherapy · 2012 · 70 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +17